Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients

NCT01449591 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythemato-telangiectatic Rosacea

Interventions

DRUG: BFH772 1% ointment
DRUG: Vehicle ointment
DRUG: Noritate® 1% cream

Sponsor

Novartis Pharmaceuticals